Stay updated on Isatuximab Combo Vs Pom-Dex in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Combo Vs Pom-Dex in Myeloma Clinical Trial page.

Latest updates to the Isatuximab Combo Vs Pom-Dex in Myeloma Clinical Trial page
- Check5 days agoChange DetectedNew site revision label 'Revision: v3.3.3' is added, and the 'HHS Vulnerability Disclosure' link and the older 'Revision: v3.3.2' label are removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedFooter revision label updated from v3.2.0 to v3.3.2 across the page. This is a minor version update and does not alter study data or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedRemoved the government funding/operating status notice from the page.SummaryDifference0.3%

- Check55 days agoChange DetectedA new history entry dated 2025-01-16 was added to the study's record history, showing an update to the study status and related sections. This provides a timestamped record of changes to the trial data.SummaryDifference0.0%

- Check84 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference8%

- Check91 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.SummaryDifference0.2%

Stay in the know with updates to Isatuximab Combo Vs Pom-Dex in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Combo Vs Pom-Dex in Myeloma Clinical Trial page.